Lorne Lucree, a beauty exec-turned-wellness disruptor, took on legacy incumbents in the allergy space in January with the launch of Wizard Wellness, a line of drug-free, microbiome-focused allergy care. Nine months later, the line has entered Walmart, CVS and Target. Glossy Beauty Podcast host Lexy Lebsack sat down with Lucree...

For the Wellness Briefing, Glossy spoke with Michelle Duffy Smith, VP of marketing, retail and events at luxury gym chain Life Time, about next week’s formal rollout of LT Social, a collection of expansive entertainment programming built around city-specific cultural events.

After two successful seasons in partnership with “Love Island,” L'Oréal-owned Maybelline has expanded its footprint this year to stunning results. Glossy sat down with Yasmin Dastmalchi, president of Maybelline New York, to learn more.

Is makeup actually back? For today’s episode of the Glossy Beauty Podcast, host Lexy Lebsack sat down with veteran celebrity makeup artist Jamie Greenberg to unpack exactly where makeup is headed next.

For the Wellness Briefing, Glossy checked in with Amy Bi, VP global brand of Estée Lauder-owned Deciem, to learn about NIOD’s launch into Sephora. Additionally, Happy Health secures $75 million to scale its FDA-cleared sleep tracker ring, SoulCycle partners with Celsius, and better-for-you period brand Rael takes on growth investment. 

Boka, the 10-year-old oral-care disruptor, has used a tried-and-true beauty marketing playbook to reach 481% year-over-year retail growth and the No. 1 toothpaste spot on Amazon, according to the brand. Glossy interviewed Boka GM Sarah Mountcastle Mitchell to learn more.

Midi Health is betting on topical skin care and body care as it diversifies its telehealth offerings to capture more women. In today's episode of the Glossy Beauty Podcast, host Lexy Lebsack interviews Dr. Kathleen Jordan, MD, Midi Health chief science officer, about the company's expansion into skin care and...

For the Wellness Briefing, Glossy is unpacking Hims & Hers Q2 earnings meeting where CEO Andrew Dudum explained the telehealth’s plan to rapidly expand into six experimental peptide therapies including BPC-157, TB-500, MOTS-c, and more. Additionally, Google unveils a new health partnership, the men’s health and wellness market surges in...

Glossy sat down with AG1 CEO Kat Cole to learn about her ambitious plan to expand the AG1 customer base through new form factors, wider distribution, “several launches per year” and a nuanced educational strategy around "good, better and best."